Mesa Laboratories (MLAB) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $1.30
- Estimate
- $2.55
- Surprise
- -49.1%
- Revenue (period 2026-06-30)
- $60.1M
- Score at report (before → after)
- 5.4 → 5.3/10
Revenue source: xbrl.
How the report landed
Mesa Laboratories (MLAB) missed the $2.55 estimate with adjusted EPS of $1.30 — a large 49.1% shortfall. TrendMatrix's engine moved from Hold (5.4/10) to Sell at 5.3/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates MLAB Sell at 5.8/10.
2 of the last 4 quarters beat the estimate; this quarter's -49.1% surprise compares with a -5.3% four-quarter average. Next scheduled report: 2027-02-03.
What supports the rating
- Positive momentum
- Positive insider activity
What argues against it
- Concentration risk — Product: Clinical Genomics consumables (80.0%)
- Analyst target reached - limited upside remaining
- Consecutive earnings misses (2)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $134.09
- Stop
- $124.70
The stock trades at 119.8× trailing but 11.4× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-11-17 — shown for context, not personalized investment advice.
MLAB at TrendMatrix's latest read
Technology names get repriced on forward expectations more than trailing prints — a quarter here is read through next-year growth and multiple, not the EPS line alone.
- Industry
- Scientific & Technical Instruments
- Market cap
- $781.3M
- P/E (fwd)
- 11.4
- P/E (ttm)
- 119.8
- 52-week range
- $69.51–$144.35
- Off 52-week high
- 7.1%
- RSI (14)
- 54
- Volume vs avg
- 1.06×
- Score today
- 5.8/10